Literature DB >> 17383346

Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome.

Traves Crabtree1, Doug Aitchison, Bryan F Meyers, Heidi Tymkew, Jennifer R Smith, Tracey J Guthrie, Nabil Munfakh, Marc R Moon, Michael K Pasque, Jennifer Lawton, Nader Moazami, Ralph J Damiano.   

Abstract

BACKGROUND: Clostridium difficile-associated diarrhea (CDAD) is a potentially preventable and often troublesome gastrointestinal complication after cardiac surgery.
METHODS: A retrospective study was performed of 8,405 cardiac surgery patients at two institutions between January 1997 and August 2004. Preoperative cardiac risk factors, perioperative factors including blood product transfusion, antibiotic utilization, and postoperative morbidity and mortality were recorded. Univariate and multivariate analyses were performed comparing C. difficile patients with a control group matched by date of surgery and institution.
RESULTS: Sixty-six of the 8,405 patients identified with toxin-positive CDAD produced an overall incidence of 0.79% (0.70% at institution A and 1.09% at institution B), with a peak overall incidence of 5.45% in June 2003. Independent prognostic factors for CDAD by multivariate analysis included advancing age (odds ratio [OR] 1.028, 95% confidence interval [CI]: 1.001 to 1.056; p = 0.034), female sex (OR 2.026, 95% CI: 1.102 to 3.722; p = 0.022), blood product transfusion (OR 3.277, 95% CI: 1.292 to 8.311; p = 0.006), and increasing cumulative days of antibiotic administration (OR 1.046, 95% CI: 1.014 to 1.080; p = 0.004). There were no differences in the proportion of fluoroquinolones, cephalosporins, or penicillin derivatives administered between groups. The diagnosis of CDAD was associated with a greater median length of mechanical ventilation (25 hours versus 12 hours, p < 0.001), longer intensive care unit stay (5 days versus 2 days, p < 0.001), and extended hospital stay (21 days versus 7 days, p < 0.001), with no difference in 30-day mortality (7.6% versus 9.5%, p = 0.80).
CONCLUSIONS: Although the overall incidence of CDAD was low, alteration in transfusion practices and antibiotic utilization may impact the development of CDAD among cardiac surgical patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383346     DOI: 10.1016/j.athoracsur.2006.10.067

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  Clostridium difficile and Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database.

Authors:  ThucNhi T Dang; Jerry T Dang; Muhammad Moolla; Noah Switzer; Karen Madsen; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

2.  Is Clostridium difficile the new bugaboo after cardiac surgery?

Authors:  Simona Silvetti; Giovanni Landoni
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Postoperative Clostridium difficile-associated diarrhea.

Authors:  William N Southern; Rabin Rahmani; Olga Aroniadis; Igal Khorshidi; Andy Thanjan; Christopher Ibrahim; Lawrence J Brandt
Journal:  Surgery       Date:  2010-02-08       Impact factor: 3.982

4.  Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Brian T Bateman; Jeremy A Rassen; Sebastian Schneeweiss; Katsiaryna Bykov; Jessica Myers Franklin; Joshua J Gagne; Jennifer M Polinski; Jun Liu; Alexander Kulik; Michael A Fischer; Niteesh K Choudhry
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-28       Impact factor: 5.209

Review 5.  Clostridium difficile infection in the intensive care unit.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

6.  Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events.

Authors:  Westyn Branch-Elliman; William O'Brien; Judith Strymish; Kamal Itani; Christina Wyatt; Kalpana Gupta
Journal:  JAMA Surg       Date:  2019-07-01       Impact factor: 14.766

7.  Blood Conservation Strategies and Liver Transplantation Transfusion-Free Techniques Derived from Jehovah's Witness Surgical Cohorts.

Authors:  Mansi Sheth; Sujit Kulkarni; Kiran Dhanireddy; Alexander Perez; Rick Selby
Journal:  Mo Med       Date:  2015 Sep-Oct

8.  A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis.

Authors:  Katherine A Kirkwood; Brian C Gulack; Alexander Iribarne; Michael E Bowdish; Giampaolo Greco; Mary Lou Mayer; Karen O'Sullivan; Annetine C Gelijns; Nishit Fumakia; Ravi K Ghanta; Jesse M Raiten; Anuradha Lala; Joseph S Ladowski; Eugene H Blackstone; Michael K Parides; Alan J Moskowitz; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-28       Impact factor: 5.209

9.  Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Jashvant Poeran; Madhu Mazumdar; Rehana Rasul; Joanne Meyer; Henry S Sacks; Brian S Koll; Frances R Wallach; Alan Moskowitz; Annetine C Gelijns
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-28       Impact factor: 5.209

10.  Risk factors for the development of Clostridium difficile colitis in a surgical ward.

Authors:  Min Jeong Kim; Byung Seup Kim; Jae Woo Kwon; So-Eun Ahn; Seung Soon Lee; Hyoung Chul Park; Bong Hwa Lee
Journal:  J Korean Surg Soc       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.